Pregled bibliografske jedinice broj: 737999
The prevalence and predictive value of dipstick urine protein in HIV-positive persons in Europe
The prevalence and predictive value of dipstick urine protein in HIV-positive persons in Europe // Abstracts of the HIV Drug Therapy Glasgow Congress 2014 ; u: Journal of the International AIDS Society 17 (2014) (S3)
Glasgow, Ujedinjeno Kraljevstvo, 2014. str. 19561-19561 (predavanje, međunarodna recenzija, sažetak, znanstveni)
CROSBI ID: 737999 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
The prevalence and predictive value of dipstick urine protein in HIV-positive persons in Europe
Autori
Mocroft, A. ; Ryom, L. ; Lapadula, G. ; Reiss, P. ; Blaxhult, A. ; Furrer, H. ; Kutsyna, G. ; Gatell, J. ; Begovac, Josip ; Kirk, O. ; Lundgren, J.
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
Abstracts of the HIV Drug Therapy Glasgow Congress 2014 ; u: Journal of the International AIDS Society 17 (2014) (S3)
/ - , 2014, 19561-19561
Skup
The HIV Drug Therapy Glasgow Congress
Mjesto i datum
Glasgow, Ujedinjeno Kraljevstvo,
Vrsta sudjelovanja
Predavanje
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
HIV infection; Renal function
Sažetak
Proteinuria (PTU) is an important marker for the development and progression of renal disease, cardiovascular disease and death, but there is limited information about the prevalence and factors associated with confirmed PTU in predominantly white European HIV+ persons, especially in those with an estimated glomerular filtration rate (eGFR) of 60 mL/min/1.73 m(2). Baseline was defined as the first of two consecutive dipstick urine protein (DPU) measurements during prospective follow-up >1/6/2011 (when systematic data collection began). PTU was defined as two consecutive DUP >1+ (>30 mg/dL) >3 months apart ; persons with eGFR <60 at either DPU measurement were excluded. Logistic regression investigated factors associated with PTU. A total of 1, 640 persons were included, participants were mainly white (n=1, 517, 92.5%), male (n=1296, 79.0%) and men having sex with men (n=809 ; 49.3%). Median age at baseline was 45 (IQR 37-52 years), and CD4 was 570 (IQR 406-760/mm(3)). The median baseline date was 2/12 (IQR 11/11-6/12), and median eGFR was 99 (IQR 88- 109 mL/min/1.73 m(2)). Sixty-nine persons had PTU (4.2%, 95% CI 3.2-4.7%). Persons with diabetes had increased odds of PTU, as were those with a prior non-AIDS (1) or AIDS event and those with prior exposure to indinavir. Among females, those with a normal eGFR (>90) and those with prior abacavir use had lower odds of PTU (Figure 1). One in 25 persons with eGFR>60 had confirmed proteinuria at baseline. Factors associated with PTU were similar to those associated with CKD. The lack of association with antiretrovirals, particularly tenofovir, may be due to the cross- sectional design of this study, and additional follow-up is required to address progression to PTU in those without PTU at baseline. It may also suggest other markers are needed to capture the deteriorating renal function associated with antiretrovirals may be needed at higher eGFRs. Our findings suggest PTU is an early marker for impaired renal function.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti, Javno zdravstvo i zdravstvena zaštita
Napomena
DOI: 10.7448/IAS.17.4.19561
POVEZANOST RADA
Projekti:
108-1080116-0098 - Epidemiološka i klinička obilježja zaraze HIV-om u Hrvatskoj (Begovac, Josip, MZOS ) ( CroRIS)
Ustanove:
Medicinski fakultet, Zagreb
Profili:
Josip Begovac
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE